FDA approves port site closure device

Medeon Biodesign recently earned Food and Drug Administration approval for AbClose, a port site closure device.

Advertisement

The device, which works like a sewing machine, can suture incision sites made during laparoscopic surgeries in less than 60 seconds.

“AbCloseTM is designed to reduce time, cost and risk of port site closure and minimize the frustrations experienced by surgical teams at the end of the surgical procedure. AbCloseTM enables secure and precise delivery of 180-degree suture bites on fascia of nearly all thicknesses,” said Yue-Teh Jang, PhD, chairman and CEO of Taiwan-based Medeon Biodesign.

 

More articles on supply chain:

6 latest FDA approvals
Mass. hospitals contribute to $3.5M equity funding round for healthcare startup
FDA should remove warning from Pfizer’s drug label, advisory panel says

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

  • Aurora, Colo.-based UCHealth Vice President of Supply Chain Richard Bagley has retired after more than four years with the health…

  • The FDA has flagged eight medical device recalls, corrections and early alerts affecting convenience kits, vascular access devices, IV administration…

Advertisement

Comments are closed.